A group of top doctors has demanded Columbia University remove Dr. Oz, citing his "egregious lack of integrity" for promoting what they call "quack treatments."
Children in Sierra Leone returned to schools on Tuesday after staying at home for nine months...
California saw a record number of deaths from the West Nile virus last year, and the state's...
Texas prison officials have acquired a small supply of pentobarbital to replenish their...
U.S. Agriculture Department scientists recently announced a new vaccine to protect chickens against a pair of potentially fatal diseases.
New momentum for a lasting fix to Medicare's doctor-payment problem shows that lawmakers may finally be recognizing what has long bothered their constituents.
A woman who tested positive for Ebola in Liberia last week is dating a survivor of the disease, a health official said Tuesday, offering a possible explanation for how she became the country's first confirmed case in weeks.
Polls generally show that the majority of Americans are on board with the death penalty. In October 2014, Gallup reported that 63 percent of Americans were in favor of capital punishment while 33 percent were opposed.
Advanced development is underway on an improved anthrax vaccine that could provide protection in fewer doses than the currently licensed anthrax vaccine and so may be more cost-effective to stockpile.
In recent years, new technology has provided a number of significant improvements to aseptic processing facilities.
Calling the federal agency that oversees vaccines a "sock puppet" for that industry, Robert Kennedy Jr. spoke out Monday in favor of allowing parents to choose whether to vaccinate their children.
The past several years have witnessed a significant increase in the rate of adoption for single use disposable systems for aseptic fill/finish applications. Paralleling recent advances in flexible aseptic filling lines, single-use disposable systems (SUDS) for aseptic fill/finish facilities promise increased flexibility and streamlined operations.
Liberians are overcoming their fears of Ebola to volunteer for a vaccine trial.
Trial has begun in a remote region of Guinea of suspects in the killings of five Ebola health workers and three journalists last September.
People want it all, don’t they? The type of cars many drive is one indicator. Crossover vehicles have become a very popular vehicle segment. They offer: practicality while still maintaining a cool factor; spaciousness with decent fuel efficiency; and car-like handling with the safety of all wheel drive for slippery conditions.
Over nearly two decades, inventions and products licensed by academic institutions contributed more than $1 trillion to the U.S. economy, according to a recent report from the Biotechnology Industry Organization.
When Texas officials launched a massive public high school steroids testing program over fears of rampant doping from the football fields to the tennis courts, they promised a model program for the rest of the country to follow. But almost no one did.
More than half of the undergraduates at the University of Oregon have not been vaccinated against meningitis, despite the fact that one student has died and five others have been sickened since January.
In a delay that some say may have cost lives, the World Health Organization resisted calling the Ebola outbreak in West Africa a public health emergency until last summer, two months after staff raised the possibility and long after a senior manager called for a drastic change in strategy.
Biogen Idec released much anticipated results from a study of a potential Alzheimer's disease treatment on Friday, showing that it slowed cognitive decline in some patients.
Evotec AG today announced that a definitive agreement for a major multi-component strategic alliance over the next five years has been signed with Sanofi. The transaction is expected to close on 31 March 2015.
Improved coordination between researchers and pharmaceutical companies could help bolster development of treatments for neurodegenerative diseases such as Alzheimer's or Parkinson's, according to an industry analyst.
An uncharacteristic joint effort by House Speaker John Boehner and his usual nemesis, Minority Leader Nancy Pelosi, to resolve a gnawing problem about how Medicare pays doctors underscores the political victories each sees in finally sweeping the issue off the deck — if they can.
The analysis by New York-based GBI Research predicted the recent expiration of patents for several of the top current therapeutics--most notably Singulair, Advair and Symbicort--would allow generic versions to curb market growth.
With a decision due by summer in a Supreme Court case that could unravel President Barack Obama's health care law, a new poll finds many Americans have heard nothing about the case. But when the potential fallout is explained, most say it would hurt the country and they would look to Congress or the states to fix it.
A judge has dismissed a lawsuit by Herbalife shareholders who claimed that the business structure and marketing practices of the weight loss and nutritional supplements company violated the law and that they lost money in what amounts to a pyramid scheme.
Vertex Pharmaceuticals has announced that the FDA approved KALYDECO® for use in children ages 2 to 5 with cystic fibrosis (CF) who have one of 10 mutations in the cystic fibrosis transmembrane conductance regulator ( CFTR) gene.
Studies show the new drug slashes bad cholesterol, or "LDL," by up to 61% and cuts heart attacks and strokes by more than half.
Bipartisan House leaders are working on a $213 billion plan to permanently change how doctors are paid for treating Medicare patients, a costly problem that's vexed Congress for years, a document circulating among lawmakers showed Tuesday.
- Page 1